Lynnae Mahaney comments on the new policy passed by the ASHP on credentialing and privileging of pharmacists by regulators, payers, and providers for collaborative drug-therapy management. Medscape Medical News
Second-generation antipsychotics (SGAs) are no better than placebo from a cost-benefit viewpoint for treating psychosis and aggression in Alzheimer disease patients, according to a report in the November issue of the Archives of General Psychiatry. Reuters Health Information
Inadequate analgesic prescriptions and poor patient adherence contribute to ineffective cancer pain management, according to findings published in the November issue of the Journal of Pain and Symptom Management. Reuters Health Information
Results of a recent study show that some patients experience "blunted" emotions when taking SSRIs. Medscape Physician Connect members discuss their experiences -- both professional and personal. Medscape Family Medicine
Treatment with candesartan, an angiotensin II type 1 receptor antagonist, improves cardiac function and exercise tolerance in some patients with nonobstructive hypertrophic cardiomyopathy, according to a pilot study in the Czech Republic. Reuters Health Information
